Telomir Pharmaceuticals, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Telomir Pharmaceuticals, Inc. Common Stock's balance sheet done over the years? Its assets were worth $4,773,768 last year. 28% of Telomir Pharmaceuticals, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $1,335,564.
Debt to Assets
| 2023 | 4773768 | 1.33M | 27.98% |
|---|
TELO Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 1.23K |
Short term investments | 0 |
Net receivables | 130K |
Inventory | 0 |
Other current assets | 303.99K |
Total current assets | 435.22K |
Non-current assets: | |
Property, Plant and Equipment | 0 |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 4.33M |
Total non-current assets | 4.33M |
Total assets | 4.77M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 101K |
Total current liabilities | 1.33M |
| Non-current liabilities: | |
Long term debt | 0 |
Deferred tax | 0 |
Other non-current liabilities | 0 |
Total non-current liabilities | 0 |
Total liabilities | 1.33M |
| Data source |